Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa
Alexander Simonis, Christoph Kreer, Alexandra Albus, et al.
Cell (2023) Vol. 186, Iss. 23, pp. 5098-5113.e19
Open Access | Times Cited: 25

Showing 25 citing articles:

A deep insight into ferroptosis in lung disease: facts and perspectives
Fan Zhang, Xiang Yu, Qiao Ma, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance
Chiara La Guidara, Roberto Adamo, Claudia Sala, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5487-5487
Open Access | Times Cited: 5
Affinitive Microbe-Imprinted Polymers for Rapid Drug-Resistant Bacteria Recognition
Yuanzi Wu, Kaiqiang Zhou, Wenhui Li, et al.
(2025)
Closed Access
Rapid and Sensitive Identification of Pseudomonas aeruginosa through a Fluorescent Probe utilizing a Magnetic 3D DNA Walker and APE1 Enzyme-Powered Cascade Signal Amplification
Kun Wang, Siyu Jiang, Yufeng Hu, et al.
Sensors and Actuators B Chemical (2025), pp. 137585-137585
Closed Access
Neutralizing human monoclonal antibodies that target the PcrV component of the Type III Secretion System of Pseudomonas aeruginosa act through distinct mechanisms
Jean-Mathieu Desveaux, Éric Faudry, Carlos Contreras‐Martel, et al.
(2025)
Open Access
Neutralizing human monoclonal antibodies that target the PcrV component of the Type III Secretion System of Pseudomonas aeruginosa act through distinct mechanisms
Jean-Mathieu Desveaux, Éric Faudry, Carlos Contreras‐Martel, et al.
(2025)
Open Access
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections
Léo Sauvat, Paul O. Verhoeven, Julie Gagnaire, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 2
Aerosolized delivery of ESKAPE pathogens for murine pneumonia models
Katharina Rox, Eva Medina
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
The Combination of Membrane Disruption and FtsZ Targeting by a Chemotherapeutic Hydrogel Synergistically Combats Pathogens Infections
Xianyuan Wei, Jintong Guo, Xiaorui Geng, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 19
Open Access | Times Cited: 1
Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reduce Pseudomonas aeruginosa burden in mice
Malika Hale, Kennidy K. Takehara, Christopher D. Thouvenel, et al.
(2024)
Open Access | Times Cited: 1
Stress triggers gut dysbiosis via CRH-CRHR1-mitochondria pathway
Yiming Zhang, Xiaoang Li, Siqi Lu, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
C-Reactive Protein Drives Potent Clearance of Blood Bacteria in the Liver by Activating the Complement System
Danyu Chen, Jiao Hu, Mengran Zhu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reducePseudomonas aeruginosaburden in mice
Malika Hale, Kennidy K. Takehara, Christopher D. Thouvenel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Unleashing the power of precision drug delivery: Genetically engineered biomimetic nanodrugs incorporating liposomal polypharmacy against multidrug-resistant bacteria
Xianyuan Wei, Jintong Guo, Xiaorui Geng, et al.
Chemical Engineering Journal (2024) Vol. 497, pp. 154515-154515
Closed Access
Antibody density on bacteria regulates C1q recruitment by monoclonal IgG but not IgM
Nathan Aymerich, Luca Johannes Schlotheuber, Olivia T. M. Bucheli, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 11
Open Access
Novel humanized anti-PcrV monoclonal antibody COT-143 protects mice from lethal Pseudomonas aeruginosa infection via inhibition of toxin translocation by the type III secretion system
Shunsuke Numata, Takafumi Hara, Masaaki Izawa, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access
Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reduce Pseudomonas aeruginosa burden in mice
Malika Hale, Kennidy K. Takehara, Christopher D. Thouvenel, et al.
(2024)
Open Access
Protective human monoclonal antibodies that target the Type III Secretion System of Pseudomonas aeruginosa inhibit translocon function
Jean-Mathieu Desveaux, Éric Faudry, Carlos Contreras‐Martel, et al.
(2024)
Open Access
Protocol for developing Pseudomonas aeruginosa type III secretion system-neutralizing monoclonal antibodies from human B cells
Alexandra Albus, Christoph Kreer, Florian Klein, et al.
STAR Protocols (2024) Vol. 5, Iss. 4, pp. 103440-103440
Open Access
Rapid point-of-care pathogen sensing in the post-pandemic era
Younju Joung, Kihyun Kim, Jing An, et al.
Trends in biotechnology (2024)
Closed Access
Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reduce Pseudomonas aeruginosa burden in mice
Malika Hale, Kennidy K. Takehara, Christopher D. Thouvenel, et al.
(2024)
Open Access
Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model
Mingya Cao, Siyu Wang, Shaohao Zhou, et al.
mSphere (2024)
Open Access
Potent antibodies have surprise source: people with chronic infections

Nature (2023) Vol. 623, Iss. 7986, pp. 227-227
Closed Access
Antibodies versus P. aeruginosa
Agustina Taglialegna
Nature Reviews Microbiology (2023) Vol. 22, Iss. 1, pp. 2-2
Closed Access
Antibodies combat Gram-negative pathogen
Sarah Crunkhorn
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 19-19
Closed Access
Page 1

Scroll to top